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Although attention-deficit/hyperactivity disorder (ADHD) is highly heritable, the 
processes by which genetic risk affects its development are poorly understood. Potential 
mechanisms that may contribute to the development of ADHD, possibly by sharing common 
genetic risk, include impairments in executive functions. The goal of the present study was to 
clarify associations among genome-wide polygenic scores, executive functions, and ADHD in a 
subsample of 4,226 youth to determine whether executive dysfunctions mediate the relationship 
between cumulative genetic risk and a dimensional trait measure of ADHD. Polygenic scores 
derived from genome-wide association studies of ADHD and (low) educational attainment, but 
not tobacco smoking, were associated with increased ADHD in a non-clinical, independent 
sample of youth. A common executive function factor mediated the relationship between genetic 
risk associated with low educational attainment and ADHD. These results demonstrate that 
polygenic risk for clinically-diagnosed ADHD is also associated with a dimensional trait 
measure of ADHD in a non-clinical sample of youth and that there is common genetic influence 
on risk for low educational attainment and ADHD. In addition, results demonstrate that 
executive dysfunction is one mechanism through which genetic variants influence ADHD and 
suggest that executive functions may be targets of intervention development. 
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Attention-deficit/hyperactivity disorder (ADHD), the most common neurodevelopmental 
disorder as classified by the Diagnostic and Statistical Manual of Mental Disorders, 5th edition 
(DSM-5), develops during childhood and often persists into adulthood (American Psychiatric 
Association [APA], 2013; Biederman, 2005). Individuals with ADHD tend to have impairments 
in executive functions (Brown, 2008; Castellanos & Tannock, 2002), defined as the cognitive 
control processes that regulate thoughts and actions (Friedman et al., 2008), which contribute to 
hyperactivity, impulsivity, inattention, and concentration problems. ADHD is associated with 
higher rates of negative academic/vocational outcomes, substantial economic costs, and social 
impairments (Barkley, Fischer, Edelbrock, & Smallish, 1990; Matza, Paramore, & Prasad, 2005; 
Pelham, Foster, & Robb, 2007), and commonly co-occurs with substance abuse (Kessler et al., 
2006; Kooij et al., 2012) and other forms of psychopathology (APA, 2013; Biederman, 2005). 
Given the prevalence and adverse impact of ADHD, there is an increased need to elucidate the 
factors and processes that contribute to its development in order to inform intervention and 
prevention strategies.  
The DSM-5 identifies two dimensions of symptoms, inattentive and hyperactive-
impulsive, that define three clinical presentations of ADHD (formerly referred to as subtypes in 
previous editions): predominantly inattentive, predominantly hyperactive/impulsive, and 
combined (APA, 2013). The classification of ADHD into three clinical presentations is an 
attempt by the ADHD working group for the DSM-5 to account for the clinical heterogeneity of 
ADHD. However, these distinctions among symptom-defined clinical presentations are not 




presentation in childhood may change to another in adolescence; Lahey, Pelham, Loney, Lee, & 
Willcutt, 2005; Lahey & Willcutt, 2010; Todd et al., 2008; Willcutt et al., 2012).  
Although a DSM-5 diagnosis of ADHD reflects a categorical approach to diagnostic 
classification, taxometric studies support a dimensional rather than a categorical structure of 
ADHD (Frazier, Youngstrom, & Naugle, 2007; Haslam et al., 2006; Marcus & Barry, 2011). In 
addition, the total number of ADHD symptoms displays a trait-like, continuous distribution in 
the general population, such that individuals who do not meet full criteria for ADHD are not 
necessarily symptom-free (Lubke, Hudziak, Derks, van Bijsterveldt, & Boomsma, 2009; Marcus 
& Barry, 2011). These findings suggest that a clinical diagnosis of ADHD may be better 
conceptualized as the extreme of a trait that varies continuously in the general population, rather 
than a discrete, categorical entity.  
Genetic studies further support the validity of a continuous trait model of ADHD in 
which clinical and sub-clinical presentations arise from a common genetic etiology, regardless of 
clinical presentation (Derks, Hudziak, Van Beijsterveldt, Dolan, & Boomsma, 2006; Faraone, 
Biederman, & Friedman, 2000a; Faraone et al., 2000b; Faraone & Mick, 2010; Groen-Blokhuis 
et al., 2014; Larsson, Anckarsater, Råstam, Chang, & Lichtenstein, 2012; McLoughlin, Ronald, 
Kuntsi, Asherson, & Plomin, 2007; Smalley et al., 2000; Todd et al., 2001). In addition, family, 
twin, and adoption studies demonstrate that genetic influences play a substantial role in the 
development of ADHD (Asherson & Gurling, 2012; Faraone & Biederman, 1998). Heritability is 
the proportion of phenotypic variance among individuals in a given population in a given 
environment that is attributable to genetic differences (Visscher, Hill, & Wray, 2008). Mean 
heritability estimates for ADHD (broadly defined; across studies that differ considerably in how 




the most heritable forms of psychopathology (Biederman, 2005; Burt, 2009; Doyle et al., 2005; 
Faraone & Mick, 2010; Faraone et al., 2005; Tannock, 1998; Waldman & Gizer, 2006). Because 
ADHD is highly heritable, investigating the genetic variants that increase risk for its 
development can help elucidate the etiology of ADHD.  
In a recent landmark study, the Cross-Disorder Group of the Psychiatric Genomics 
Consortium (2013) analyzed data from the largest existing genome-wide association studies 
(GWAS) for ADHD and reported the heritability due to common genetic variants (i.e., the 
combined influence of all genotyped single nucleotide polymorphisms [SNPs]) for ADHD to be 
28%. However, no GWAS, including a meta-analysis (Neale et al., 2010), has yet to identify a 
single SNP that is significantly associated with ADHD. Many factors have been proposed to 
account for these nonsignificant findings, though given the results of the Cross-Disorder Group 
of the Psychiatric Genomics Consortium (2013), it is probable that the existing studies have been 
underpowered to detect significant genome-wide associations. One way to increase statistical 
power in molecular genetics research is to analyze dimensional trait measures instead of the 
traditional diagnostic category case-control methodology (Hawi et al., 2015; Lasky-Su et al., 
2008).  
The null GWAS results thus far may also be explained by inadequate sample sizes to 
account for the stringent genome-wide significance level of p < 5 × 10-8 that is utilized to correct 
for multiple testing (Visscher, Brow, McCarthy, & Yang, 2012) and small effect sizes of 
individual genetic variants (Hawi et al., 2015). Indeed, the combined sample size of 5,415 
individuals (2,064 trios [father, mother, and child with ADHD], 896 non-trio cases [child with 
ADHD only], and 2,455 controls) in the largest existing GWAS of ADHD (Neale et al., 2010) is 




For example, the combined sample size of 150,064 individuals (36,989 cases and 113,075 
controls) in a recent GWAS of schizophrenia identified 128 independent SNPs (Schizophrenia 
Working Group of the Psychiatric Genomics Consortium, 2014), the GWAS of educational 
attainment identified three SNPs that predict approximately one month of schooling per allele in 
a sample of 126,559 individuals (Rietveld et al., 2013), and the GWAS of smoking behavior 
identified eight SNPs that predict smoking initiation in a sample of 143,023 individuals (Tobacco 
and Genetics Consortium, 2010). These results suggest that with large enough samples, genetic 
variants can be identified as reliably predictive of complex, partly heritable outcomes. 
Given that numerous common genetic variants with very small individual effects 
contribute to complex phenotypes, another way to increase power when examining complex 
genetic traits is to analyze many genetic variants simultaneously rather than individually (Belsky 
& Beaver, 2011; Chabris, Lee, Cesarini, Benjamin, & Laibson, 2015; Derringer et al., 2010; 
Rietveld et al., 2013). The very small effect sizes of individual SNPs from GWAS can be 
summed to create a polygenic score (i.e., a cumulative genetic risk composite containing a 
number of common genetic variants weighted by the effect sizes from GWAS; Dudbridge, 2013; 
Plomin, 2013; Wray et al., 2014). For example, the Schizophrenia Working Group of the 
Psychiatric Genomics Consortium (2014) demonstrated that polygenic scores accounted for 18% 
of the variance in risk for schizophrenia, whereas each of the 128 significant genome-wide SNPs 
contributed only a miniscule fraction of that effect on risk.  
Polygenic scores can involve the aggregation of anywhere from several significant 
genome-wide SNPs to thousands of or even all genotyped SNPs, weighted by their individual 
effect sizes estimated from GWAS. This latter method is commonly referred to as a genome-




polygenic scores has been shown to be greater in comparison to other polygenic methods (e.g., 
only including SNPs with p-values less than a defined threshold; Rietveld et al., 2013). In 
addition, polygenic scores are able to predict outcomes even when none of the individual SNPs 
rise to the level of statistical significance (Visscher et al., 2012). This suggests that the effect 
sizes from Neale et al.’s (2010) ADHD GWAS may be summed together to estimate an 
individual’s overall genetic risk for ADHD, although the lack of power in the original study 
resulted in none of the individual genetic variants meeting the genome-wide corrected threshold 
of p < 5 × 10-8. Polygenic scores derived from GWAS for ADHD have already proved to be 
fruitful in predicting ADHD phenotypes in clinical and non-clinical samples (Groen-Blokhuis et 
al., 2014; Hamshere et al., 2013; Martin, Hamshere, Stergiakouli, O’Donovan, & Thapar, 2014; 
Stergiakouli et al., 2015). Although previous studies have demonstrated that ADHD-related 
phenotypes can be predicted by polygenic scores, replication studies in independent samples are 
critical to establishing the credibility of genotype-phenotype associations (Chanock et al., 2007).  
Proxy-Phenotype Approach  
Not only are the genetic architectures of complex traits highly polygenic, they are also 
pleiotropic (i.e., each genetic variant may contribute to many different phenotypes; Chabris et al., 
2015). In addition to being a useful method in attempting to replicate the aggregate findings of 
common genetic variants from GWAS for a particular phenotype, polygenic scores can be 
utilized to assess the genetic overlap between complex phenotypes. That is, a polygenic score 
identified to predict one outcome may be used as a “proxy” to predict a correlated phenotype of 
interest. For example, ADHD is often associated with substance use behaviors like tobacco 
smoking (Gray & Upadhyaya, 2009; Kollins, McClernon, & Fuemmeler, 2005; Lambert & 




Tercyak, Lerman, & Audrain, 2002) and with poorer academic outcomes such as low educational 
attainment (Barkley, Fischer, Smallish, & Fletcher, 2006; Kuriyan et al., 2013; Polderman, 
Boomsma, Bartels, Verhulst, & Huizink, 2010; Mannuzza, Klein, Bessler, Malloy, & LaPadula, 
1993; Pingault et al., 2011). Given that genetic factors have been shown to play a role in tobacco 
smoking (Tobacco and Genetics Consortium, 2010; Schnoll, Johnson, & Lerman, 2007) and 
educational attainment (Branigan, McCallum, & Freese, 2013; de Zeeuw, de Geus, & Boomsma, 
2015; Rietveld et al., 2013), their phenotypic correlations with ADHD could be accounted for by 
correlated genetic variants (Krapohl et al., 2014; McClernon & Kollins, 2008; Young, Stallings, 
Corley, Krauter, & Hewitt, 2000).  
This approach, which has been called the proxy-phenotype method, is especially useful 
when there is not a large enough GWAS sample for the phenotype of interest, but there is for a 
correlated phenotype (Rietveld et al., 2014b). Although the Neale et al. (2010) GWAS was 
presumably underpowered to detect significant genome-wide associations for ADHD (N = 
5,415), adequately large sample sizes exist for GWAS of tobacco smoking (N = 143,023; 
Tobacco and Genetics Consortium, 2010) and educational attainment (N = 126,559; Rietveld et 
al., 2013). Because ADHD is highly correlated with both tobacco smoking and low educational 
attainment, the results of GWAS for these phenotypes may be good proxies to identify genetic 
variants associated with ADHD. In fact, a polygenic score derived from Rietveld et al.’s (2013) 
educational attainment GWAS has already been shown to predict ADHD symptoms in an 
independent sample of 12-year-olds (de Zeeuw et al., 2014), though to date no reported study has 
examined whether a polygenic score derived from a tobacco GWAS predicts an ADHD 
phenotype.  




Although it is well established that ADHD has a strong genetic etiology (Tannock, 1998), 
the mechanisms by which genetic risk affects its development are poorly understood. This is 
most likely due to the fact that ADHD is a complex phenotype with a potentially heterogeneous 
genetic architecture (Doyle et al., 2005; Faraone et al., 2005). To address these challenges, the 
identification of endophenotypes, defined as heritable manifestations of phenomena that index 
liability for the development of a disorder (Gottesman & Gould, 2003; Miller & Rockstroh, 
2013), has been advocated as a way to help shed light on the processes involved in the 
phenotypic manifestation of ADHD and to test and revise theories of psychopathology 
(Vaidyanathan, Vrieze, & Iacono, 2015). 
One potential endophenotype is executive dysfunction. Executive dysfunction is an 
impairment in executive functions, which generally refer to cognitive processes (e.g., planning, 
updating, shifting, inhibiting, sequencing) that regulate and control goal-directed, future-oriented 
behavior (Alvarez & Emory, 2006; Chan, Shum, Toulopoulou, & Chen, 2008; Diamond, 2013). 
Although there are various models of executive function (e.g., Banich, 2009; Dosenbach, Fair, 
Cohen, Schlaggar, & Peterson, 2008; Lezak, 2004; Miller & Cohen, 2001), individual 
differences in executive functions appear to reflect both unity (i.e., common/shared abilities) and 
diversity (i.e., specific/unique abilities; Miyake & Friedman, 2012; Miyake et al., 2000). Given 
the necessity of these cognitive processes in orchestrating adaptive behavior, it is not surprising 
that impairments in executive functions are associated with severe impairments in everyday life, 
in domains such as employment, educational attainment, relationships, and activities of daily 
living (Angst, 1999; Clark, Prior, & Kinsella, 2002; Grigsby, Kaye, Baxter, Shetterly, & 




impairments in executive functions also tend to characterize individuals with ADHD (Biederman 
et al., 2004; Murphy & Barkley, 1996).  
Executive dysfunction has been proposed to be a candidate endophenotype for ADHD, as 
empirical studies have provided consistent evidence of an association between impairments in 
executive functions and ADHD (Barkley, 1997; Brown, 2008; Castellanos & Tannock, 2002; 
Nigg, 2001; Pennington & Ozonoff, 1996; Willcutt, Doyle, Nigg, Faraone, & Pennington, 2005). 
These impairments appear to begin early in life (Fischer, Barkley, Smallish, & Fletcher, 2005; 
Hinshaw, Carte, Fan, Jassy, & Owens, 2007; Rinsky & Hinshaw, 2011), and early impairments 
in executive functions may precede the onset of ADHD-specific symptoms (Berlin, Bohlin, & 
Rydell, 2004; Friedman et al., 2007).  
Individuals with ADHD have been shown to exhibit impairments in several distinct facets 
of executive function, including inhibition (Barkley, 1997; Nigg, 2001; Pennington & Ozonoff, 
1996), shifting (Oades & Christiansen, 2008; van Mourik, Oosterlaan, & Sergeant, 2005), 
updating working memory (Martinussen, Hayden, Hogg-Johnson, & Tannock, 2005; Willcutt et 
al., 2005), and attentional control (Pasini, Paloscia, Alessandrelli, Porfirio, & Curatolo, 2007). 
Although some researchers have hypothesized that a specific executive dysfunction, such as an 
impairment in inhibition (Barkley, 1997; Crosbie, Pérusse, Barr, & Schachar, 2008; Slaats-
Willemse, Swaab-Barneveld, de Sonneville, van der Meulen, & Buitelaar, 2003), attentional 
control (Bellgrove, Hawi, Gill, & Robertson, 2006), or updating (Castellanos & Tannock, 2002), 
is the “core” deficit of ADHD, these specific executive dysfunctions may reflect a pattern of 
general deficits in the common factor of executive function. In other words, it is unclear as to 
whether a specific or common executive dysfunction leads to the manifestation of the disorder. 




executive function tasks, and executive dysfunction alone is not a necessary or sufficient 
criterion for a diagnosis of ADHD (Moffitt et al., 2015; Nigg, Willcutt, Doyle, & Sonuga-Barke, 
2005; Sergeant, Geurts, & Oosterlaan, 2002; Tsal, Shalev, & Mevorach, 2005; Willcutt et al., 
2005).  
It is likely that ADHD is a heterogeneous disorder that arises from the additive or 
interactive effects of a number of different factors across multiple levels of analysis, both within 
and outside the individual (e.g., neuropsychological deficits, genetic variants, motivational 
reward deficits, prenatal/parental risk factors; Knopik et al., 2005; Nigg et al., 2005; Luman, 
Oosterlaan, & Sergeant; 2005; Sonuga-Barke, Bitsakou, & Thompson, 2010; Willcutt et al., 
2005). In order to advance our understanding of the etiology of ADHD, research on 
endophenotypes has been advocated as a way of identifying causal mechanisms and providing 
new strategies to test and revise theories of psychopathology (Vaidyanathan et al., 2015). By 
improving our understanding of the mechanisms through which genetic risk influences ADHD, 
novel interventions that target specific endophenotypes can be developed. In addition, the 
identification of distinct endophenotypes for ADHD may have implications for future 
classification systems by leading to the refinement of clinical diagnoses (Miller, Clayson, & Yee, 
2014). Given that both executive functions and ADHD are highly heritable (Doyle et al., 2005; 
Faraone et al., 2005; Friedman et al., 2008) and share genetic liability (Bidwell, Willcutt, 
DeFries, & Pennington, 2007; Coolidge, Thede, & Young, 2000; Kuntsi, Neale, Chen, Faraone, 
& Asherson., 2006), executive functions are viable candidates for endophenotypic mediators of 
the relationship between additive genetic risk (i.e., polygenic scores) and ADHD.  




Although ADHD has a strong genetic etiology, the processes by which genetic risk 
affects its development are poorly understood. Potential mechanisms that may contribute to the 
development of ADHD, possibly through the pathway of common genetic risk, include 
impairments in executive functions. Thus, the purpose of the present study was to clarify 
associations among polygenic scores, executive functions, and ADHD in a large sample of youth 
to determine whether executive dysfunctions explain (mediate) the relationship between 
cumulative genetic risk and a dimensional trait measure of ADHD.  
First, we determined whether genome-wide polygenic scores derived from GWAS of 
ADHD (Neale et al., 2010), (low) educational attainment (Rietveld et al., 2013), and tobacco 
smoking (Tobacco and Genetics Consortium, 2010) predicted a dimensional trait measure of 
ADHD in a non-clinical, independent sample of youth. Second, for the polygenic scores that 
were significantly associated with ADHD, we tested whether a common executive function 
factor and/or specific variance derived from measures of attentional control, inhibition, updating, 
and shifting mediated the relationship between genetic risk and ADHD. It was predicted that the 
three genome-wide polygenic scores would be positively associated with ADHD in a non-
clinical, independent sample of youth, and that these relationships would be mediated by both 






ADHD sample. The Psychiatric Genomics Consortium’s GWAS of childhood ADHD 
consisted of a final sample size of 2,064 trios (father, mother, and child with ADHD), 896 non-
trio cases (child with ADHD only), and 2,455 controls. The majority of the sample is of western 
European descent. Complete GWAS results for 1,206,461 SNPs are publicly available from 
https://www.med.unc.edu/pgc/downloads. See Neale et al. (2010) for additional information on 
this dataset.  
Educational attainment sample. The Social Science Genetic Association Consortium’s 
GWAS of educational attainment consisted of a final sample of 126,559. Educational attainment 
was defined as an individual’s total years of schooling. Complete GWAS results for 2,310,087 
SNPs are publicly available from http://www.thessgac.org/#!data/kuzq8. See Rietveld et al. 
(2013) for additional information on this dataset. 
Tobacco smoking sample. The Tobacco and Genetics Consortium’s GWAS of smoking 
behavior assessed tobacco smoking in a sample size of 143,023 participants. Tobacco smoking 
was assessed using a binary measure of smoking initiation (ever versus never been a regular 
smoker). Complete GWAS results for 2,455,846 SNPs are publicly available from 
https://www.med.unc.edu/pgc/downloads. See Tobacco and Genetics Consortium (2010) for 
additional information on this dataset. 
Target Sample  
The target sample consisted of youth from the Neurodevelopmental Genomics: 
Trajectories of Complex Phenotypes study, accessed and downloaded from the National 




accession: phs000607.v1.p1). Participants were recruited from the Children’s Hospital of 
Philadelphia (CHOP) or CHOP affiliates and volunteered to participate in genomic studies of 
complex pediatric disorders (Gur et al., 2012; Satterthwaite et al., 2012). In order to be eligible 
for the study, potential participants needed to be proficient in English and able to complete all 
study procedures. Participants provided either informed consent or assent (depending on whether 
the participant was over or under the age of 18), and parental consent was required for 
participants under the age of 18. A total of 8,741 participants between the ages of 8 and 22 (M = 
13.76; SD = 3.68)1 provided blood samples for genetic analysis and completed both a structured 
clinical assessment and a computerized neurocognitive battery (Gur et al., 2012, 2010). All 
procedures were approved by Institutional Review Boards at the University of Pennsylvania and 
CHOP. 
ADHD Trait Measure  
In order to assess various forms of psychopathology, an abbreviated computerized 
version (Merikangas, Avenevoli, Costello, Koretz, & Kessler, 2009; Merikangas, Dierker, & 
Szatmari, 1998) of the Kiddie-Schedule for Affective Disorders and Schizophrenia (K-SADS; 
Kaufman, Birmaher, Brent, & Rao, 1997) was completed by participants if they were at least 11 
years of age or by their parent/legal guardian if they were under the age of 11.   
Given that ADHD is highly heritable regardless of whether it is measured as a categorical 
disorder or as a continuous trait (Nadder, Silberg, Rutter, Maes, & Eaves, 2001), ADHD was 
operationalized as a continuous dimension of nine observable traits in the present study. Items 
based on trait-like patterns of behavior (as opposed to items related to age of onset, 
settings/contexts, or degree of impairment) were selected for inclusion in the total ADHD trait 
score. The nine variables that were selected were: (1) “Did you often have trouble paying 
                                                          




attention or keeping your mind on your school, work, chores, or other activities that you were 
doing?” (2) “Did you often have problems following instructions and often fail to finish school, 
work, or other things you meant to get done?” (3) “Did you often dislike, avoid, or put off school 
or homework (or any other activity requiring concentration?” (4) “Did you often lose things you 
needed for school or projects at home (assignments or books) or make careless mistakes in 
school work or other activities?” (5) “Did you often have trouble making plans, doing things that 
had to be done in a certain kind of order, or that had a lot of different steps?” (6) “Did you often 
have people tell you that you did not seem to be listening when they spoke to you or that you 
were daydreaming?” (7) “Did you often have difficulty sitting still for more than a few minutes 
at a time, even after being asked to stay seated, or did you often fidget with your hands or feet or 
wiggle in your seat or were you "always on the go"?” (8) “Did you often blurt out answers to 
other people's questions before they finished speaking or interrupt people abruptly?” (9) “Did 
you often join other people's conversations or have trouble waiting your turn (e.g., waiting in 
line, waiting for a teacher to call on you in class)?” For each of these items, respondents 
indicated on a dichotomous (yes/no) response scale whether they or their child exhibited each 
trait. These nine items were coded 0 for “no” and 1 for “yes.” A total ADHD trait score was 
calculated by summing these responses to give an observed range of 0-9 (M = 2.43; SD = 2.75), 
with higher scores reflecting higher levels of the ADHD trait. Because the distribution of the 
ADHD score was positively skewed due to an excess of zero values, the variable was log-
transformed — i.e., ln(ADHD score + 1)2. 
Executive Function Measures 
                                                          
2 Analyses were also conducted with the unadjusted (raw) ADHD trait variable, but there were no substantial 




 Participants were administered a 1-hour long computerized neurocognitive battery that 
was designed to assess accuracy and speed of performance for several major domains of 
cognition (Gur et al., 2012, 2010). The following four variables were used as executive function 
measures. 
Shifting. The Penn Conditional Exclusion Test is a measure of abstraction and mental 
flexibility. Participants were asked to identify which of four objects did not belong with the other 
three objects based on one of three possible sorting principles (e.g., size, shape, line thickness), 
and they were guided by feedback throughout the task. After 10 successful trials in which the 
participant demonstrated that the sorting principle had been solved, the sorting principle would 
change without informing the participant (Gur et al., 2010, 2012; Kurtz, Ragland, Moberg, & 
Gur, 2004). The variable that was used as a measure of shifting was the accuracy score, which 
was calculated by multiplying the proportion of correct responses by the number of categories 
attained (out of three possible). 
Attentional control. The Penn Continuous Performance Test (PCPT) is a measure of 
attentional control. Participants were instructed to respond to 7-segment displays that were 
presented at a rate of one per second whenever the display forms a digit (for the first half of the 
test) or a letter (for the second half of the test). The version of the PCPT that was used in this 
study (Gur et al., 2012) had been shortened from six minutes (three minutes for digits and three 
minutes for letters) in the original PCPT (Gur et al., 2011, 2010; Kurtz et al., 2004) to three 
minutes (1.5 minutes for each). The accuracy score (i.e., total number of correct responses to 
number trials and letter trials) was used in analyses as the attentional control variable.  
Inhibition. In order to measure inhibition, the total number of commission errors (i.e., 




Updating. The letter n-back test is a measure of updating, a core component of working 
memory (Miyake et al., 2000). Participants were presented with letters for 500 ms and then had 
an additional 2000 ms to respond by pressing the spacebar. In the 0-back condition, participants 
responded to a single target (i.e., “X”). In the 1-back condition, they responded if the letter was 
identical to that preceding it. In the 2-back condition, they responded if the letter was identical to 
that presented two trials back. Following a training period, the test presented three blocks of each 
of the three conditions, for a total of 135 trials (Gur et al., 2001, 2010; Ragland et al., 2002). The 
accuracy score (i.e., the number of correct responses) was used in analyses as the updating 
variable.  
Transformations and Data Trimming  
 The directionality of the executive function variables were adjusted as needed so that 
higher values indicated better task performance and lower values indicated impaired task 
performance (i.e., executive dysfunction). In order to reduce skewness and kurtosis and to 
improve normality, the executive function variables were transformed if the Shapiro-Wilk test of 
normality indicated that the data were not normal (p < .05). A cube transformation was applied to 
the shifting and updating variables, and a log transformation was applied to the inhibition 
variable. After transformations were applied, outliers were detected using the median and the 
median absolute deviation (MAD), which is defined as the median of the absolute deviations 
from the median of all data (Hampel, 1974; Tukey, 1977). A deviation of three units was used as 
a very conservative threshold for the detection criterion (Miller, 1991) so that outliers that were 
greater or less than the median ± 3 × MAD were replaced with a value that was equal to the 




each of the measures. The MAD method was used due to its robustness to outliers (Leys, Ley, 
Klein, Bernard, & Licata, 2013).  
Genotyping and Quality Control Assessment  
Genomic DNA was extracted from blood samples, and genome-wide genotyping of 
single nucleotide polymorphisms (SNPs) was conducted using the following Illumina (Illumina, 
Inc., San Diego, CA, USA) and Affymetrix (Affymetrix, Inc., Santa Clara, CA, USA) 
genotyping arrays: Illumina HumanHap550 (version 1.1; n = 556), Illumina HumanHap550 
(version 3.0; n = 1,914), Illumina HumanOmniExpress-12 (version 1.1; n = 1,657), Illumina 
Human610-Quad (version 1B; n = 3,804), Affymetrix Axiom (n = 722), and Affymetrix Array 
6.0 (n = 66). Both Affymetrix platforms parsed genotypes with the forward allele, while all 
Illumina platforms were recoded from a 1/2 format to the DNA nucleotide base pair format (A, 
C, G, & T) using strand files courtesy of Will Rayner 
(http://www.well.ox.ac.uk/~wrayner/strand/). Platforms were merged together, which resulted in 
a combined data set of 1,453,091 SNPs.  
SNP and sample quality control checks were performed using PLINK, version 1.07 
(Purcell et al., 2007). SNPs were excluded if they showed little variation (minor allele frequency 
[MAF] < 5 × 10-5), had a call rate less than 90%, or were not present in the reference samples. A 
total of 289,815 SNPs remained after SNP quality control. Redundant (i.e., correlated) SNPs 
were then pruned according to the variance inflation factor-based linkage disequilibrium 
protocols in PLINK, leaving 116,020 SNPs in approximate linkage equilibrium (i.e., 
uncorrelated with each other) for analysis. Although 305 of the remaining SNPs (0.26%) were 
not in Hardy-Weinberg equilibrium (HWE; p < 5 × 10-6), we elected not to remove them from 




samples applied in this study (e.g., Neale et al., 2010). Descriptive statistics for the remaining 
116,020 SNPs are available upon request.  
Participants were removed if they had a SNP call rate less than 90%. In order to be 
consistent with the reference samples, participants were also removed if they were not of 
European ancestry as approximated by pairwise identity-by-state distance clustering using 
multidimensional scaling (MDS) analysis (see Figure 1). All participants genotyped on the two 
Affymetrix platforms (Axiom and Array 6.0) were removed due to missingness (low genotyping) 
compared to the set of SNPs available on the majority of participants genotyped on Illumina 
arrays, and all participants genotyped on the Illumina HumanHap550 (version 1.1) platform were 
removed due to platform-wide IBS distance dissimilarity from the remaining three Illumina 
platforms, suggesting potentially biasing differences in the way genotypes had been called for 
that particular array.  
In order to assess genetic similarity among participants (i.e., sample relatedness), we 
examined the distribution of pi-hat values for each individual (where increasing values of pi-hat, 
ranging from zero to one, indicate greater similarity in individuals’ genotypes due to relatedness 
or population substructure). There were no values greater than .15, which suggests that the 
participants are an ancestrally homogeneous sample of unrelated individuals. After quality 
control and selection for European ancestry to match the reference samples, the final sample 
consisted of 4,226 participants (2,094 females; 49.6%) between the ages of 8 and 21 (M = 13.76; 
SD = 3.61),3 with 99.1% self-reporting European ancestry.  
Genome-Wide Polygenic Scores 
                                                          





Three genome-wide polygenic scores were calculated for each participant in the target 
sample using the weighted sum score of SNPs obtained from the effect sizes (β1SNP1 + β2SNP2 
+ β3SNP3 + … + βnSNPn) of the reference samples. Specifically, an ADHD polygenic score was 
derived from a reference sample of individuals with a clinical diagnosis of ADHD (Neale et al., 
2010). To estimate polygenic risk for low educational attainment, the effect sizes for educational 
attainment, defined as an individual’s total years of schooling, were multiplied by the observed 
effect alleles for each participant (Rietveld et al., 2013). This polygenic score was reverse scored 
so that higher polygenic risk was associated with lower educational attainment. The Tobacco and 
Genetics Consortium’s (2010) GWAS of smoking behavior assessed tobacco smoking using a 
binary measure of smoking initiation. Polygenic risk for tobacco smoking was derived for each 
participant by multiplying the number of observed effect alleles with the smoking initiation 
effect sizes. The effect sizes (β’s) for each SNP from the three reference samples are available 
upon request. It was expected that the polygenic scores would predict higher ADHD trait scores.  
Data Analysis 
To test whether polygenic risk for ADHD, low educational attainment, and tobacco 
smoking were positively associated with ADHD in the target sample, ADHD was regressed onto 
each polygenic score in separate linear regression analyses, adjusting for age, sex (coded: female 
= 0, male = 1), genotyping platform (to correct for genotyping errors; Teo, 2008), and 20 MDS 
ancestry dimensions (to correct for population stratification; Price et al., 2006; Rietveld et al., 
2014a; Tian, Gregersen, & Seldin, 2008). Age was included as a covariate because it was 
negatively associated with the ADHD and low educational attainment polygenic scores, and 
positively associated with the four executive function variables; sex was included as a covariate 




greater low educational attainment polygenic scores, attentional control, inhibition, and updating 
(see Table 1). Because the genotyping platform variable had three levels (i.e., Illumina 
HumanHap550 version 3.0, Illumina HumanOmniExpress-12, and Illumina Human610-Quad), it 
was converted into two dummy codes (using Illumina Human610-Quad as the reference group 
because it was the largest category). All analyses were conducted using IBM SPSS Statistics 
version 23 (IBM Corp., Armonk, NY).  
For the genome-wide polygenic scores that were significantly associated with ADHD, we 
tested whether executive functions mediate this relationship, adjusting for age, sex, genotyping 
platform, and 20 MDS ancestry dimensions. A factor analysis was conducted with the four 
standardized executive function variables (attentional control, inhibition, updating, and shifting) 
in order to obtain a common executive function factor score for each participant. In order to 
control for the shared variance among the executive function measures, a regression was run for 
each executive function variable as predicted by the common executive function factor to obtain 
unstandardized residuals to use in the mediation analyses. These residualized (“specific”) 
variables therefore represent the unique variance in each executive function variable that is not 
shared with the common executive function factor. Mediation analyses were conducted using the 
PROCESS version 2.15 macro (Hayes, 2013), and the significance of the indirect effect was 
tested using 1,000 bootstrap samples. It is important to note that we acknowledge the limitations 
in inferring causation or directionality from cross-sectional mediation models.  
A power analysis was conducted using the ‘pwr’ package in R (Champely, 2012; 
Champely et al., 2015) to determine the power necessary to detect significant associations 
between the polygenic scores and ADHD in the available sample. Using an effect size estimate 




(2013), the final sample of 4,226 participants at p < .05, one-tailed, had 37% statistical power to 
detect an effect size of 2%. We had 80% power at p < .05, one-tailed, to detect an effect size of 






 As can be seen in Table 1, ADHD was positively associated with the ADHD and low 
educational attainment polygenic scores, and negatively associated with all four executive 
function variables. The ADHD polygenic score was positively associated with the tobacco 
smoking polygenic score, and negatively associated with inhibition. The tobacco smoking 
polygenic score was negatively associated with the low educational attainment polygenic score 
and positively associated with updating. The low educational attainment polygenic score was 
negatively associated with all four executive function variables. All of the executive function 
variables were positively correlated.  
Regression Analyses 
Although there was no significant association between the polygenic score for tobacco 
smoking and ADHD (β = .021, p = .208, R2 = .021, ∆R2 = 0.0%), the ADHD polygenic score 
was associated with increased ADHD (β = .033, p = .032, R2 = .022, ∆R2 = 0.1%). In addition, 
the low educational attainment polygenic score was associated with increased ADHD (β = .054, 
p = .004, R2 = .023, ∆R2 = 0.2%).4 Because the ADHD and low educational attainment polygenic 
scores were uncorrelated (r = -.02), these were independent findings.   
Factor Analysis 
 Several tests were used to assess the suitability of the executive function variables for 
factor analysis. The Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy was 0.680, 
indicating that the degree of common variance among the four variables is “mediocre” (Dziuban 
& Shirkey, 1974; Kaiser, 1974), but acceptable (Tabachnick & Fidell, 2001). Bartlett’s test of 
                                                          
4 Regression analyses were also conducted without the covariates, but there were no substantial differences between 




sphericity was significant (2 (6) = 1416.980, p < .001), indicating that the correlation matrix is 
significantly different from an identity matrix (i.e., the variables are correlated highly enough to 
provide a reasonable basis for factor analysis). The diagonals of the anti-image correlation matrix 
were all over 0.650, supporting the inclusion of each item in the factor analysis.  
Given these overall factorability indicators, an exploratory factor analysis using principal 
axis factor extraction was conducted with all four variables in order to obtain a latent executive 
function factor. Analysis revealed one factor with an eigenvalue over one, which explained 
45.01% of the variance shared among the individual executive function variables. A scree plot 
(see Figure 2) showed the substantial drop-off in eigenvalues after the first factor. Loadings on 
the common factor ranged from 0.375 for shifting to 0.635 for updating (see Figure 3). The 
communalities (h2), the variance in each item explained by the extracted factor, were 0.333 for 
attentional control, 0.227 for inhibition, 0.404 for updating, and 0.141 for shifting.  
A common executive function factor score was obtained for each participant using a least 
squares regression approach. In addition, the common factor was partialled out from each 
executive function variable to obtain residualized (“specific”) variables that represent the unique 
variance in each executive function variable that is not shared with the common executive 
function factor. 
Mediation Analyses 
 As can be seen in Figure 4, there were no significant mediation effects of the ADHD 
polygenic score on ADHD through either the common or residualized executive function 
variables. However, there was a significant indirect effect of the low educational attainment 
polygenic score on ADHD through the common executive function factor, ab = 0.0046, 95% 




executive function factor accounted for 19.95% of the total effect. In addition, there was a 
significant indirect effect of the low educational attainment polygenic score on ADHD through 
the residualized inhibition variable, ab = -0.0007, 95% BCa CI [-0.0019, -0.0001]. The 
residualized inhibition variable accounted for -3.12% of the total effect5, indicating inconsistent 
mediation (i.e., the direct and indirect effects of the independent variable on the dependent 
variable have opposite signs; MacKinnon, Krull, & Lockwood, 2000; Tzelgov & Henik, 1991). 
There were no significant mediation effects of the low educational attainment polygenic score on 
ADHD through the residualized variables of attentional control, updating, or shifting.  
 For the two mediation models that showed significant effects, mediation analyses were 
also conducted without the covariates. There remained a significant indirect effect of the low 
educational attainment polygenic score on ADHD through the common executive function factor 
without inclusion of the covariates, ab = 0.0040, 95% BCa CI [0.0027, 0.0059]. The common 
executive function factor could account for 18.24% of the total effect. However, the indirect 
effect of the low educational attainment polygenic score on ADHD through the residualized 
inhibition variable was no longer significant without inclusion of the covariates, ab = -0.0004, 
95% BCa CI [-0.0013, 0.0001], suggesting that the initial findings of inconsistent mediation 
were spurious and not robust.   
                                                          
5 The proportion of the effect that is mediated (the ratio of the indirect effect over the total effect) should be 





The goal of the present study was to clarify associations among genome-wide polygenic 
scores, executive dysfunction, and ADHD in a large sample of youth to determine whether 
specific executive functions and/or a common executive function factor mediate the relationship 
between three genome-wide polygenic scores (derived from GWAS of ADHD, educational 
attainment, and tobacco smoking) and a dimensional trait measure of ADHD. Analyses revealed 
that both the ADHD and low educational attainment polygenic scores were associated with 
increased ADHD, and that a common executive function factor mediated the relationship 
between genetic risk associated with low educational attainment and ADHD.  
Polygenic Scores for a Dimensional Trait Measure of ADHD 
Although the largest existing ADHD GWAS did not identify a single genetic variant that 
reached genome-wide significance (Neale et al., 2010), the sum total of genetic risk implied by 
the GWAS predicted ADHD in the present study (R2 = .022). This result suggests that polygenic 
risk for clinically-diagnosed ADHD based on effect sizes from Neale et al. (2010) is also 
associated with a dimensional trait measure of ADHD in a non-clinical sample of youth. This 
finding supports prior studies demonstrating common genetic overlap between a clinical 
diagnosis of ADHD and a dimensional trait measure of ADHD, and therefore provides further 
support at a molecular genetics level that liability for ADHD is the extreme of a trait that varies 
continuously in the general population (Groen-Blokhuis et al., 2014; Hamshere et al., 2013; 
Larsson et al., 2012; Martin et al., 2014; Stergiakouli et al., 2015).  
In addition, a polygenic score associated with reduced educational attainment in an adult 
sample (Rietveld et al., 2013) predicted ADHD in the present study (R2 = .023). This result is 




risk for low educational attainment and ADHD (de Zeeuw et al., 2014; Saudino & Plomin, 
2007). Moreover, this result extends de Zeeuw and colleagues’ (2014) finding of a low 
educational attainment polygenic score predicting ADHD in a sample of 12-year-olds to an 
independent sample of youth between the ages of 8 and 21. Given that genetic variants 
associated with educational attainment can explain part of the variance in ADHD, polygenic risk 
for low educational attainment can be used as a proxy for ADHD.  
It is important to note that even though both the ADHD and low educational attainment 
polygenic scores predicted ADHD in an independent sample of youth, these two polygenic 
scores were uncorrelated and are thus independent findings. This suggests that both polygenic 
scores are predicting unique variance in ADHD and may represent different developmental 
pathways. In addition, even though the polygenic scores for ADHD (R2 = 2.2%) and low 
educational attainment (R2 = 2.3%) accounted for only a small amount of the phenotypic 
variance in ADHD in this study, these effect sizes are consistent with the effect sizes that are 
being reported for other complex behavioral traits that likely have similar genetic architectures. 
For example, Rietveld and colleagues (2013) proposed that the results of their educational 
attainment GWAS serve as a benchmark for evaluating the plausibility of behavioral genetics 
findings for complex behavioral traits, and our effect sizes are in the range of the effect size 
estimates of R2 = 2% to 3% reported for their educational attainment polygenic scores in adults. 
Given that the explanatory power of polygenic scores is dependent on the size of the GWAS 
samples from which they are derived (Chabris et al., 2015; Rietveld et al., 2013), it is likely that 
the variance accounted for in ADHD by polygenic scores will increase as the sample sizes of 




Although ADHD often co-occurs with tobacco smoking, the polygenic score derived 
from the tobacco smoking GWAS in adults (Tobacco and Genetics Consortium, 2010) did not 
predict ADHD in an independent sample of youth. This non-significant result suggests that the 
phenotypic association between tobacco smoking and ADHD cannot be accounted for by genetic 
variants associated with tobacco smoking at the genome-wide level in this sample, which is 
counter to findings from candidate gene studies that have provided evidence of a single genetic 
polymorphism being associated with both ADHD and tobacco smoking (e.g., Laucht, Hohm, 
Esser, Schmidt, & Becker, 2007; Thakur, Sengupta, Grizenko, Choudhry, & Joober, 2012). 
Given that different SNPs were significantly associated with each of the smoking phenotypes in 
the tobacco smoking GWAS, it is possible that a polygenic score derived from another smoking 
phenotype (e.g., number of cigarettes smoked per day) may be a better proxy-phenotype for 
ADHD than the binary measure of smoking initiation that was selected for use in this study. 
Indeed, there was a negative association between the tobacco smoking and low educational 
attainment polygenic scores (r = -.149, p < .001), which indicates that there are correlated 
genetic variants between tobacco smoking and educational attainment at the genome-wide level. 
Although this significant correlation was unexpected, there is evidence that greater educational 
attainment is associated with greater nicotine use (Johnson, Hicks, McGue, & Iacono, 2009). 
Thus, because ADHD was predicted by the low educational attainment polygenic score in this 
study, it is possible that shared non-genetic/environmental factors may better account for the 
phenotypic association between tobacco smoking and ADHD than shared genetic variants.  
Executive Function Mediation of Polygenic Risk on ADHD 
In order to understand the processes by which the ADHD and low educational attainment 




endophenotypic mediators of the relationship between polygenic risk and ADHD. Neither a 
common nor specific executive dysfunction mediated the relationship between the ADHD 
polygenic score and ADHD; however, a common executive function factor mediated the 
relationship between genetic risk associated with low educational attainment and ADHD. These 
results suggest that executive dysfunction may be one mechanism through which genetic variants 
associated with low educational attainment influence ADHD, whereas the association between 
the ADHD polygenic score derived from a categorical diagnosis of ADHD and dimensionally-
defined ADHD in the current study cannot be accounted for via executive dysfunction. It thus 
appears that unique mechanisms that are distinct from executive function account for the 
relationship between polygenic risk derived from a GWAS of clinical patients with ADHD and a 
dimensional trait measure of ADHD. In addition, the common executive function factor only 
accounted for 20% of the relationship between the low educational attainment polygenic score 
and ADHD. This suggests that other endophenotypes also play a role in the relationship between 
polygenic risk associated with low educational attainment and ADHD phenotypes.  
Although the relationship between the low educational attainment polygenic score and 
ADHD was not mediated by the residualized variables of attentional control, updating, or 
shifting, the residualized inhibition variable mediated the relationship between genetic risk 
associated with low educational attainment and ADHD. However, the direct and indirect effects 
of the low educational attainment polygenic score on ADHD have opposite signs (which is why 
the proportion of the effect that is mediated is negative), indicating that the residualized 
inhibition variable is an inconsistent mediator (“suppressor”) of the relationship between the low 
educational attainment polygenic score and ADHD (MacKinnon et al., 2000; Shrout & Bolger, 




mediator strengthens the relationship between the independent and dependent variables by 
producing a direct effect that is greater in magnitude than the total effect (Rucker, Preacher, 
Tormala, & Petty, 2011). This situation suggests that another mediator may be present whose 
indirect effect’s sign is equal to that of the direct effect (Hair, Hult, Ringle, & Sarstedt, 2014).  
Indeed, there is evidence that inhibition is completely subsumed by a common executive 
function factor (Friedman, Miyake, Robinson, & Hewitt, 2011; Friedman et al., 2008), which 
could possibly account for the inconsistent mediation results. Because the inhibition variable was 
embedded within a specific task and was not a latent factor, this variable also included 
measurement error and systematic variance attributable to non-executive function processes 
associated with commission errors on the PCPT (“task-impurity” problem; Miyake & Friedman, 
2012). It is therefore probable that once the shared executive function variance was removed 
from the inhibition variable, only measurement error and systematic variance attributable to non-
executive function processes (e.g., processing speed) were left over—there may have been no 
unique variance left for inhibition after accounting for common executive function variance. 
However, taking into account the difference in effect sizes for the two significant mediation 
models (19.95% for the common executive function factor versus 3.12% for the residualized 
inhibition variable) and the fact that the residualized inhibition variable did not mediate the 
relationship between the low educational attainment polygenic score and ADHD after removing 
the covariates from the model, it is likely that the inconsistent mediation result is spurious and 
not robust (i.e., a “false positive” finding). It will be important for future studies to probe this 
inconsistent mediation result to determine whether it is spurious and/or what non-executive 





Several potential limitations of the present study should be noted. First, in order to reduce 
false positives due to population stratification (Haldar & Ghosh, 2012), participants were 
removed from analyses if they were not of European ancestry in order to match the reference 
samples. Thus, our results may have limited generalizability because our analyses were 
conducted on a homogenous sample of participants with European ancestry. Second, each of the 
four specific executive function variables was embedded within a specific task and therefore also 
included measurement error and systematic variance attributable to non-executive function 
processes associated with the specific task (“task-impurity” problem; Miyake & Friedman, 
2012). This may partially explain why attentional control, updating, and shifting did not mediate 
the relationship between the low educational attainment polygenic score and ADHD after the 
common executive function factor was partialled out (and could also explain the inconsistent 
mediation results for inhibition). In order to determine whether specific latent executive function 
factors are also endophenotypic mediators of the relationship between polygenic risk and 
ADHD, it will be important for future studies to examine these and other specific executive 
functions as latent variables by administering multiple tasks designed to measure each specific 
executive function. Third, it is unclear whether the mediation results are specific to executive 
function abilities or related to cognitive abilities more broadly. Given that children with ADHD 
tend to score lower on tests of general cognitive ability than individuals without ADHD (Frazier, 
Demaree, & Youngstrom, 2004; Kuntsi et al., 2004), it is possible that a more general cognitive 
factor and/or other cognitive processes better account for the relationship between genetic risk 
associated with low educational attainment and ADHD. Fourth, causal inferences cannot be 
made from our results due to the cross-sectional study design. Although we were unable to 




is evidence that early impairments in executive functions precede the onset of ADHD-specific 
symptoms (Berlin et al., 2004; Friedman et al., 2007). Nevertheless, longitudinal studies are 
needed to clarify how the development of executive function processes and the effects of genetic 
variation temporally and mechanistically relate to changes in ADHD. 
Conclusion  
The use of dimensional constructs and alternative conceptualizations of mental disorders 
reflect the current approach to studying psychopathology in order to elucidate causal 
mechanisms and to improve diagnostic systems (e.g., National Institute of Mental Health 
Research Domain Criteria [RDoC]; Cuthbert, 2014, 2015; Insel et al., 2010; Morris & Cuthbert, 
2012; Yee, Javitt, & Miller, 2015). Results of the present study add to the literature by 
identifying two polygenic scores derived from GWAS of ADHD and educational attainment that 
predict ADHD dimensionally, rather than categorically. In addition, findings suggest that the 
association between the low educational attainment polygenic score and a dimensional trait 
measure of ADHD can be partially explained via executive dysfunction; however, executive 
dysfunction could not account for the relationship between the ADHD polygenic score and 
ADHD.  
Research on endophenotypes allows for new ways to test and revise etiological theories 
of psychopathology and also has implications for classification, treatment, and prevention 
(Miller et al., 2014; Vaidyanathan et al., 2015). The results of this study extend theory and 
research on individual differences in vulnerability to ADHD, in turn elucidating potential 
intervention targets. By explicating a mechanism by which genetic variants influence a 
dimensional measure of ADHD, the present findings provide further support that interventions 




be important for future studies to identify additional mechanisms through which genetic risk 







TABLE & FIGURES 
 
Table 1. Bivariate correlations for ADHD, genome-wide polygenic scores (GPS), executive 
function variables, age, and sex 
 1 2 3 4 5 6 7 8 9 10 
1. ADHD -- 
2. ADHD GPS .03* -- 
3. Tobacco GPS .01 .08** -- 
4. Low edu GPS .06** -.02 -.15** -- 
5. AttCon -.07** -.02 .02 -.10** -- 
6. Inhibition -.12** -.04* .01 -.05** .30** -- 
7. Updating -.07** -.01 .03* -.08** .37** .28** -- 
8. Shifting -.08** .00 -.00 -.06** .20** .20** .27** -- 
9. Age .03 -.04** .01 -.04** .45** .54** .38** .22** --  
10. Sex .11** .01 -.00 -.03* -.08** -.18** -.04* .03 -.09** --  
 
Note. Low edu = low educational attainment. AttCon = attentional control. Sex was coded: 





Figure 1. Multidimensional scaling plot based on pairwise identity-by-state distance clustering 
 
Figure 1 is a multidimensional scaling (MDS) plot of ancestry differences in 8,741 individuals 
derived from the genome relationship matrix that accounts for the genetic substructure of the 
data (Wray et al., 2013). Each dot represents an individual and is color coded by self-reported 
ethnicity. The two axes correspond to a reduced representation of the data in two MDS 
dimensions (“components”). The first dimension is anchored at one end by those of self-reported 
Eurpean American ancestry and at the other end by those of self-reported African American 
ancestry. The second dimension differentiates self-reported European American ancestry from 




Figure 2. Scree plot of eigenvalues from exploratory factor analysis of four executive function 
variables 
 
Figure 2 is a scree plot depicting the eigenvalues against the corresponding number of factors 
derived from an exploratory factor analysis of four executive function variables. The scree plot 




Figure 3. One-factor exploratory factor analysis model of executive function variables  
 
 
Note. EF = executive function. The top numbers are factor loadings. The bottom numbers 
represent the unique variance of each variable given by: 1− h2 (communality) = item specific 











Note. EF = executive function. Res. = residualized. AttCon = attentional control. † = denotes 
inconsistent mediation. The total effect is the standardized regression coefficient in front of 
parentheses. The direct effect is the standardized regression coefficient inside parentheses. Effect 
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